Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Sep 10, 2015
Continuous Precipitation of Nano-Crystals, Cocrystals and Amorphous Solid Dispersions
Read more
Scientific Article
/ Sep 10, 2015
Screening Methodologies to Expedite the Formulation Development of Amorphous Solid Dispersions
Read more
Scientific Article
/ Jul 27, 2015
Hovione and Invion sign development agreement for first inhaled non-steroidal anti-inflammatory for asthma
Read more
Scientific Article